Suppr超能文献

PTCH1 和 PTCH2 中的遗传罕见和常见变异导致生殖癌易感性。

Inherited rare and common variants in PTCH1 and PTCH2 contributing to the predisposition to reproductive cancers.

机构信息

Department of Molecular Diagnostics, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, PR China.

Department of Molecular Diagnostics, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, PR China.

出版信息

Gene. 2022 Mar 10;814:146157. doi: 10.1016/j.gene.2021.146157. Epub 2022 Jan 4.

Abstract

PTCH1 and PTCH2 are associated with nevoid basal cell carcinoma syndrome and basal cell carcinoma. We determined the prevalence of their common and rare variants in 877 patients with various reproductive cancers and 296 healthy subjects. Using targeted next-generation sequencing, we found significantly statistical associations of the minor alleles at seven common variants of PTCH1 and PTCH2 with a decreased risk of reproductive cancers (P = 9.69 × 10). Among these variants, two haplotype blocks in high linkage disequilibrium were consisted of rs2277184, rs2066829 and rs2236405 sites at PTCH1 and rs3795720, rs11573590 and rs11211040 sites at PTCH2. Single marker and haplotype-based analysis consistently revealed a decreased risk of reproductive cancers especially breast and prostate cancers in the subjects carrying the minor alleles, and on the contrary, an increased risk for major alleles. Healthy control subjects showed a higher rate of rare variants than that of cancer patients (P = 0.017). Notably, two frameshift variants (p.Ser391* and p.Cys101Alafs*48) of PTCH2 with deleterious effects were found in only four cancer patients. Higher frequencies of variants of PTCH genes might have a protective role against the development of reproductive cancers, whereas rare deleterious variants of PTCH2 might predispose a carrier to reproductive cancers.

摘要

PTCH1 和 PTCH2 与神经嵴发育不良性基底细胞癌综合征和基底细胞癌有关。我们在 877 名患有各种生殖系统癌症的患者和 296 名健康对照者中确定了它们常见和罕见变异的流行率。使用靶向下一代测序,我们发现 PTCH1 和 PTCH2 的七个常见变异的次要等位基因与生殖系统癌症风险降低之间存在显著的统计学关联(P=9.69×10)。在这些变异中,PTCH1 上的 rs2277184、rs2066829 和 rs2236405 位点以及 PTCH2 上的 rs3795720、rs11573590 和 rs11211040 位点构成了两个高度连锁不平衡的单倍型块。单标记和基于单倍型的分析一致表明,携带次要等位基因的受试者生殖系统癌症(特别是乳腺癌和前列腺癌)的风险降低,而主要等位基因的风险增加。健康对照者的罕见变异率高于癌症患者(P=0.017)。值得注意的是,在仅有的四名癌症患者中发现了 PTCH2 的两个无义变异(p.Ser391和 p.Cys101Alafs48),具有有害影响。PTCH 基因变异的较高频率可能对生殖系统癌症的发生具有保护作用,而 PTCH2 的罕见有害变异可能使携带者易患生殖系统癌症。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验